Z Sultana et al. Gastro Hep Advances 2022; 1: 869-881: Open Access! Symptom Scores and pH-Impedance: Secondary Analysis of a Randomized Controlled Trial in Infants Treated for Gastroesophageal Reflux
In the introduction, the authors note: “Gastroesophageal reflux (GER) is a physiological process defined as the passage of gastric contents into the esophagus with or without regurgitation and vomiting, while GER disease (GERD) is pathophysiologic and occurs when GER is associated with troublesome symptoms and/or complications.”
“This distinction between GER and GERD remains enigmatic among survivors in the neonatal intensive care unit (NICU). Reflux-type symptoms (arching, irritability, acute life-threatening events, coughing, failure to thrive, and swallowing difficulties) in this high-risk infant population can be troublesome to the parent and provider, and empiric management using pharmacological and dietary changes are common albeit with consequences.”
Methods: “Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) and 24-hour pH-impedance data were analyzed from 94 infants…[and] Longitudinal data from 40 infants that received randomized GER therapy (proton pump inhibitor [PPI] with or without feeding modifications) for 4 weeks followed by 1-week washout were analyzed. Relationships between I-GERQ-R and pH-impedance metrics (acid reflux index, acid and bolus GER events, distal baseline impedance, and symptoms) were examined and effects of treatments compared.”
- Acid-suppressive therapy with feeding modifications had no effect on symptom scores or pH-impedance metrics. Clearance of refluxate worsened despite PPI therapy.
- Correlations between I-GERQ-R and pH-impedance metrics were weak or non-existent, indicating that physicians cannot depend only on the questionnaire to diagnose and treat GERD in premature infants.
My take: This study shows that reflux symptoms are unreliable in establishing a diagnosis of reflux disease in infants. In addition, medical treatments were not beneficial in infants with abnormal pH-impedance metrics. Perhaps, it is time to acknowledge that we cannot even agree what reflux “disease” is in (premature) infants.
Related blog posts:
- Good Episode of Bowel Sounds on Reflux
- Acid Suppression for Laryngomalacia -Handed This Article to My ENT Colleagues
- Do Acid Blockers Given to Infants Increase the Risk of Allergic Disease?
- Something Useful for ALTEs (BRUEs)
- 2018 AAP: Reflux Management in Preterm Infants
- 2018 Pediatric Gastroesophageal Reflux Guidelines
- How Many Kids with Reflux have Reflux?
- pH Probe Testing: Rumors of My Death are Premature
- Better to do a coin toss than an ENT exam to determine reflux
- Blaming Reflux for BRUEs -Not Changing Despite Guideline Recommendations
- Even the Experts Agree: pH-MII is a “Flawed Test” | gutsandgrowth
- No Effect of Proton Pump Inhibitors and Irritability on … – gutsandgrowth
- How Likely is Reflux in Infants with “Reflux-like … – gutsandgrowth